← All trials
NCT02408562
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2015
- Primary completion
- Oct 31, 2015
- Completion date
- Oct 31, 2015
- First posted
- Apr 3, 2015
- Last posted
- Jan 27, 2016
- Enrollment
- 1
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Newron PharmaceuticalsLead sponsor
- European UnionCollaborator
- Lund UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.